Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. [electronic resource]
Producer: 20180521Description: 5969-5976 p. digitalISSN:- 2219-2840
- Adult
- Antiviral Agents -- therapeutic use
- Carbamates
- China
- Drug Therapy, Combination -- methods
- Graft Rejection -- prevention & control
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- therapeutic use
- Kidney Transplantation -- adverse effects
- Liver Cirrhosis -- prevention & control
- Male
- Middle Aged
- Pilot Projects
- Prospective Studies
- Pyrrolidines
- RNA, Viral -- isolation & purification
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
- Transplant Recipients
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.